October 27, 2017
Christine Masonick, Breast Program Manager, has suggested the following language which reflects the NCH philosophy on breast imaging
Breast cancer is the most common non-skin cancer and the second leading cause of cancer death for women in the United States. Before the introduction of widespread mammographic screening in the mid-1980s, the death rate from breast cancer in the U.S. had remained unchanged for more than four decades. Since 1990, the death rate has declined by at least 38 percent. Much of this change is attributed to early detection with mammography.
The American College of Radiology breast cancer screening experts have reviewed data from randomized trials, observational studies, U.S. screening data and other peer-reviewed literature to update their recommendations.
Mammography screening has consistently been shown to significantly reduce breast cancer mortality over a variety of study designs. The American College of Radiology recommends annual mammography screening starting at age 40 for women of average risk of developing breast cancer. This recommendation is based on maximizing proven benefits, which include a substantial reduction in breast cancer mortality afforded by regular screening and improved treatment options for those diagnosed with breast cancer. The risks associated with mammography screening are also considered to assist women in making an informed choice.